MedPath
HSA Approval

SOPROXEN TABLET 250 mg

SIN09804P

SOPROXEN TABLET 250 mg

SOPROXEN TABLET 250 mg

June 4, 1998

POLYMEDIC TRADING ENTERPRISE PTE LTD

POLYMEDIC TRADING ENTERPRISE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPOLYMEDIC TRADING ENTERPRISE PTE LTD
Licence HolderPOLYMEDIC TRADING ENTERPRISE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

M01AE02

naproxen

Manufacturer Information

POLYMEDIC TRADING ENTERPRISE PTE LTD

BERLIN PHARMACEUTICAL INDUSTRY CO LTD

Active Ingredients

NAPROXEN SODIUM EQV NAPROXEN

250 mg

Naproxen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SOPROXEN TABLET 250 mg - HSA Approval | MedPath